title: Usefulness of detection of minimal residual disease by 'hypermetaphase' fluorescent in situ hybridization after allogeneic BMT for chronic myelogenous leukemia.
abstract: Hypermetaphase FISH (HMF), a molecular cytogenetic procedure combining the long term mitotic arrest of bone marrow cultures with detection of a specific chromosomal rearrangement by fluorescence in situ hybridization (FISH), has recently been shown to be effective in determining the frequency of Philadelphia chromosome positive (Ph+) cells in the bone marrow of chronic myelogenous leukemia (CML) patients undergoing treatment. By combining the probe for the Ph chromosome with one for the detection of the X chromosome, we used HMF to monitor the presence of malignant cells within the emerging host cell population in the marrow of a CML patient that had undergone sex-mismatched allogeneic bone marrow transplantation. In successive studies, we detected 0.5% and 1.75% Ph+ cells, respectively, confirmed by Western blot analysis for p210 protein. These readings occurred concordantly with a repopulation of host-derived diploid female cells. Standard G-band cytogenetic analyses did not detect any Ph+ cells at these time points. Intervention with donor lymphocyte infusion reinduced complete remission. This experience indicates that HMF is useful to identify low levels of repopulation by Ph+ cells in the marrow post-BMT at a stage when intervention is most efficacious.
authors.affiliation: Section of Blood and Marrow Transplantation, University of Texas, MD Anderson Cancer Center, Houston, USA.
authors.forename: D
authors.initials: D
authors.lastname: Seong
authors.forename: S
authors.initials: S
authors.lastname: Giralt
authors.forename: H
authors.initials: H
authors.lastname: Fischer
authors.forename: K
authors.initials: K
authors.lastname: Hayes
authors.forename: A
authors.initials: A
authors.lastname: Glassman
authors.forename: R
authors.initials: R
authors.lastname: Arlinghaus
authors.forename: J
authors.initials: J
authors.lastname: Xu
authors.forename: H
authors.initials: H
authors.lastname: Kantarjian
authors.forename: M
authors.initials: M
authors.lastname: Siciliano
authors.forename: R
authors.initials: R
authors.lastname: Champlin
mesh_terms: D000017:ABO Blood-Group System; D000328:Adult; D001853:Bone Marrow / Q000648:ultrastructure*; D016026:Bone Marrow Transplantation; D005260:Female; D006801:Humans; D017404:In Situ Hybridization, Fluorescence; D007621:Karyotyping; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000097:blood / Q000235:genetics / Q000473:pathology / Q000628:therapy*; D014184:Transplantation, Homologous
chemical_list: D000017:ABO Blood-Group System